Nabriva Therapeutics

Rafal Kosakowski developed an identity for Nabriva Therapeutics. Founded in 2006 as a spin-off of the Antibiotics Research Institute of Sandoz in Vienna, Nabriva Therapeutics is a commercial-stage biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections.